Clinical outcome between familial and sporadic origin for MSI colon cancer patients treated with adjuvant FOLFOX +/- cetuximab: A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials
ANNÉE
2019
AUTEURS
Zaanan A, Shi Q, Taieb J, Alberts S, Meyers J, Smyrk T, Julié C, Zawadi A, Tabernero J, Mini E, Goldberg R, Folprecht G, Laethem J, Le Malicot K, Sargent D, Laurent-Puig P, Sinicrope FA
CONGRÈS/REVUE
JCO Precision Oncology
LIEN PUBLICATIONS ASSOCIÉES